Mewelo GLP-1 prices
Mewelo: prices at a glance
- M
Compounded, not FDA-approved
Semaglutide
about $236/mo
- M
Compounded, not FDA-approved
Tirzepatide
about $252/mo
Physician-supervised GLP-1 programs operated by Nanoom Medical Group, with clinics in California and Maryland: a month-to-month membership, with the medication charged separately. Mewelo has 2 sourced self-pay GLP-1 offers here. Advertised entry prices: Semaglutide about $236/mo; Tirzepatide about $252/mo. Compounded products are not FDA-approved. Plan terms, fees and the check date are listed with each quote.
Search by medication, provider or treatment goal. Examples follow.
2 offers · US self-pay · 0 maintenance quotes
- Semaglutide via Mewelo (membership plus medication)
Semaglutide · Compounded
Compounded · Not FDA-approvedAdvertised priceabout $236/moSupply period unverified; excluded from cost ranking.
Checked
Third-party report
Maintenance priceView offerNo separate dose price verified
Price conditions & source
Advertised price: about $707 over 3 months by its own example: the $199 monthly Medicine membership plus about $110 of medication charged separately; month to month, cancel anytime
Available in California and Maryland. Medication is charged apart from the membership and rises with the dose, so the figure is its example at the dose it refers to. Compounded medicines are not FDA-approved; its page does not say whether what it dispenses is compounded, and we list it here because the medication is priced by a dispensing pharmacy.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source (mewelo.com) - Tirzepatide via Mewelo (membership plus medication)
Tirzepatide · Compounded
Compounded · Not FDA-approvedAdvertised priceabout $252/moSupply period unverified; excluded from cost ranking.
Checked
Third-party report
Maintenance priceView offerNo separate dose price verified
Price conditions & source
Advertised price: about $757 over 3 months by its own example: the $199 monthly Medicine membership plus about $160 of medication charged separately; month to month, cancel anytime
Available in California and Maryland. Medication is charged apart from the membership and rises with the dose, so the figure is its example at the dose it refers to. Compounded medicines are not FDA-approved; its page does not say whether what it dispenses is compounded, and we list it here because the medication is priced by a dispensing pharmacy.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source (mewelo.com)
Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.
Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.
The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of October 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.
Mewelo GLP-1 cost: common questions
How much does semaglutide cost through Mewelo?
Semaglutide: about $236/mo (about $707 over 3 months by its own example: the $199 monthly Medicine membership plus about $110 of medication charged separately; month to month, cancel anytime). Checked Nov 6, 2026; each quote names its source in the table. Compounded semaglutide is not an FDA-approved product.
How much does tirzepatide cost through Mewelo?
Tirzepatide: about $252/mo (about $757 over 3 months by its own example: the $199 monthly Medicine membership plus about $160 of medication charged separately; month to month, cancel anytime). Checked Nov 6, 2026; each quote names its source in the table. Compounded tirzepatide is not an FDA-approved product.
Does Mewelo offer FDA-approved GLP-1 medication or compounded versions?
The Mewelo offers tracked here are compounded: Semaglutide; Tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.
Which states does Mewelo serve?
Mewelo's own page says it serves only California and Maryland. Its words: "Available in California & Maryland" (read Nov 6, 2026). Which GLP-1 sellers serve your state
When were Mewelo prices last checked?
Each quote carries its own check date and links the page it was read from: Nov 6, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.
Are you Mewelo? See how sellers are listed, how to correct a price, and the badge listed sellers can show.